Soft­Bank, RA keep pump­ing mon­ey in­to biotech star­tups as pro­tein degra­da­tion play­er bags $102M

On the heels of a $500 mil­lion biobucks deal with Am­gen a few weeks ago fol­low­ing the ap­point­ment of for­mer Astel­las CBO Per­ci­val Bar­ret­to-Ko as their new CEO in No­vem­ber, TPD start­up Plex­i­um is on a mon­ey spree. And to­day the biotech has nabbed a big B round from some mar­quee biotech back­ers.

The start­up said it closed the round with $102 mil­lion, which Bar­ret­to-Ko told End­points News will last the com­pa­ny 2-3 years. The syn­di­cate in­cludes a few A-list in­vestors on board, in­clud­ing Soft­Bank, RA Cap­i­tal and Sur­vey­or Cap­i­tal. Cal­i­for­nia-based in­vestors BVF Part­ners and TCG X led the round, with TCG X part­ner Cari­ad Chester now a mem­ber of Plex­i­um’s board.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER